Another plausible explanation is that elevated RDW levels in cancer patients may be attributed to prolonged inflammatory responses and increased circulating cytokine levels, possibly causing damage to red blood cell membranes and influencing erythropoietin production, ultimately leading to an increase in RDW [28]. The gene discussed is EPO; the disease is cancer.